Category Development

Policy Coherence To Boost East Africa Pharmaceutical Industry

KAMPALA, UGANDA - The pharmaceutical industry in the East African Community is approaching a higher level of production quality and manufacturing practices. To benefit the industry and increase access to medicines, stakeholders are working towards a united regulatory policy framework aimed at harmonising industrial, health and regulatory policies.

Are The UN And WIPO Drifting Apart?

NEW YORK – As some of the most powerful people on earth prepare to gather here later this week at the United Nations to discuss the biggest problems and opportunities facing humankind for the next 15 years, mention of a key issue underlying many themes – intellectual property – is hard to find. Also hard to find is reference to the UN agency responsible for the issue, the World Intellectual Property Organization.

Health Advocates Press United States On WTO LDC IP Waiver

Several leading public health groups have sent a letter to United States Trade Representative and US Patent and Trademark Office director asking for more transparency on the US position on a request by least-developed countries to indefinitely extend their World Trade Organization intellectual property waiver on pharmaceutical products.